We are live on ! Find out more
TNGX icon

Tango Therapeutics
TNGX

38 hedge funds and large institutions have $135M invested in Tango Therapeutics in 2020 Q3 according to their latest regulatory filings, with 38 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

63.33% more ownership

Funds ownership: 0% → 63.33% (+63%)

Holders
38
Holders Change
+38
Holders Change %
–
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$12.8M
2
SCA
Southpoint Capital Advisors
New York
+$8.68M
3
ACA
Avoro Capital Advisors
New York
+$8.17M
4
BI
BVF Inc
California
+$8.17M
5
CAM
Cormorant Asset Management
Massachusetts
+$8.17M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$12.9M +$12.8M +1,250,000 New
SCA
2
Southpoint Capital Advisors
New York
$8.81M +$8.68M +850,000 New
ACA
3
Avoro Capital Advisors
New York
$8.67M +$8.17M +800,000 New
CAM
4
Cormorant Asset Management
Massachusetts
$8.37M +$8.17M +800,000 New
BI
5
BVF Inc
California
$8.29M +$8.17M +800,000 New
EC
6
EcoR1 Capital
California
$8.29M +$8.17M +800,000 New
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$6.22M +$6.13M +600,000 New
BlackRock
8
BlackRock
New York
$6.22M +$6.13M +600,000 New
RI
9
RTW Investments
New York
$6.22M +$6.13M +600,000 New
Alyeska Investment Group
10
Alyeska Investment Group
Illinois
$5.22M +$5.15M +504,000 New
BCLSI
11
Bain Capital Life Sciences Investors
Massachusetts
$5.18M +$5.11M +500,000 New
PA
12
Perceptive Advisors
New York
$5.18M +$5.11M +500,000 New
SB
13
Samsara BioCapital
California
$5.18M +$5.11M +500,000 New
VA
14
VR Adviser
New York
$5.18M +$5.11M +500,000 New
WP
15
Woodline Partners
California
$5.18M +$5.11M +500,000 New
TCM
16
Tang Capital Management
California
$4.86M +$4.79M +468,750 New
Citadel Advisors
17
Citadel Advisors
Florida
$3.69M +$3.48M +340,318 New
DCM
18
Driehaus Capital Management
Illinois
$3.25M +$3.06M +300,000 New
APM
19
Avidity Partners Management
Texas
$3.11M +$3.06M +300,000 New
Janus Henderson Group
20
Janus Henderson Group
United Kingdom
$2.31M +$2.23M +218,282 New
LGM
21
Logos Global Management
California
$2.07M +$2.04M +200,000 New
NCM
22
Nantahala Capital Management
Connecticut
$2.07M +$2.04M +200,000 New
CCM
23
Consonance Capital Management
New York
$1.86M +$1.84M +180,000 New
TCM
24
Tenor Capital Management
New York
$1.55M +$1.53M +150,000 New
CIM
25
Cowen Investment Management
New York
$1.04M +$1.02M +100,000 New
1
2

TNGX Hedge Fund Activity: Q3 2020 in Review

38 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Tango Therapeutics (TNGX) for Q3 2020, worth a combined $135M.

Buyers outnumbered sellers: 38 funds opened new TNGX positions and 0 closed out — a net gain of 38 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $12.8M.

  • 38 institutional investors held Tango Therapeutics (TNGX) as of Q3 2020, up from 0 in Q2 2020.
  • Funds reported $135M of Tango Therapeutics stock for Q3 2020.
  • 38 funds opened new Tango Therapeutics positions in Q3 2020 and 0 closed out, a net change of +38 holders.
  • The largest Tango Therapeutics buyer in Q3 2020 was RA Capital Management, an estimated $12.8M added.

Based on aggregated 13F filings for Q3 2020.